A History of Stroke/Transient Ischemic Attack Indicates High Risks of Cardiovascular Event and Hemorrhagic Stroke in Patients with Coronary Artery Disease

Ahajournals: 12/31/12

Background—Randomized trials of antithrombotics in coronary artery disease (CAD) have identified prior stroke/TIA as a marker of increased intracranial bleeding risk. We aimed to further characterize the risk of ischemic and bleeding events associated with a history of stroke/TIA in patients with CAD.

Methods and Results—From the international REACH registry of atherothrombosis, baseline characteristics and 4-year follow-up of 26,389 patients with CAD, including 4460 patients (16.9%) with a history of stroke/TIA, were analyzed. Patients with prior stroke/TIA had a higher rate of recurrent CV events (CV death, MI, or stroke) than patients without: adjusted HR (1.52, 95% CI, 1.40 to 1.65; p<0.001) and specifically of non-fatal ischemic stroke (adjusted HR 3.06; 95% CI, 2.62 to 3.57; p<0.001) and non-fatal hemorrhagic stroke rates (adjusted HR, 1.76; 95% CI, 1.00 to 3.08; p=0.05). Excess risk for non-fatal hemorrhagic stroke appeared confined to the 1st year following a stroke/TIA (adjusted HR, 3.03; 95% CI, 1.51 to 6.08 for the first year) and was particularly high in patients receiving dual antiplatelet therapy (adjusted HR 5.21; 95% CI, 1.24 to 21.90). Read More

National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2011 National Minority Quality Forum, Inc. All Rights Reserved.